Enoxaparin-Associated Dermal Necrosis: A Consequence of Cross-Reactivity with Heparin-Mediated Antibodies
Authors:
- 1 March 1997
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 31 (3) , 323-326
Abstract
Objective: To describe a patient with enoxaparin-induced dermal necrosis and to review previously reported cases of skin manifestations associated with low-molecular-weight heparins. Case Summary: A 43-year-old white woman with adult respiratory distress syndrome developed localized dermal necrosis and thrombocytopenia secondary to subcutaneous administration of unfractionated heparin. Upper extremity thrombi that had developed after administration of subcutaneous heparin at an outside hospital were treated with subcutaneous enoxaparin. Although platelet counts remained stable during enoxaparin therapy, dermal necrosis developed at the injection site. Parenteral anticoagulant therapy was discontinued and the necrotic lesions secondary to enoxaparin resolved with minimal local care. Discussion: Numerous cases of dermal necrosis secondary to heparin administration have been reported while this reaction secondary to enoxaparin use has been reported only briefly. It has been postulated that dermal necrosis secondary to heparin is associated with heparin-induced thrombocytopenia and is a result of heparin-mediated thrombosis in the microvasculature. Antibodies to heparin have cross-reactivity with enoxaparin; therefore, dermal necrosis secondary to enoxaparin may occur by a similar mechanism. Conclusions: Although enoxaparin-associated dermal necrosis appears to be a rare occurrence, we advise against the use of enoxaparin or other low-molecular-weight heparins in patients with a previous history of heparin-associated thrombocytopenia or heparin-induced dermal necrosis.Keywords
This publication has 16 references indexed in Scilit:
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Skin necrosis after subcutaneous low molecular weight heparin injectionAmerican Journal of Hematology, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Heparin‐induced skin reaction due to two different preparations of low molecular weight heparin (LMWH)British Journal of Haematology, 1993
- Heparin skin necrosis-an important indicator of potentially fatal heparin hypersensitivityClinical and Experimental Dermatology, 1993
- SKIN NECROSIS WITH A LOW MOLECULAR WEIGHT HEPARINBritish Journal of Haematology, 1992
- Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reactionBritish Journal of Dermatology, 1990
- Skin Necrosis due to Intravenous HeparinDermatology, 1989
- HYPERSENSITIVITY REACTIONS TO HEPARIN: DELAYED ONSET THROMBOCYTOPENIA AND NECROTIZING SKIN LESIONSAnz Journal of Surgery, 1986
- Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin-Induced Skin NecrosisAnnals of Surgery, 1979